Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission. Printed by #UserName#, #Company_Name#


Printed By

UsernamePublicRestriction

‘Be careful what you wish for with Sue Sharpe’s replacement’

Pharmacists should "be careful what they wish for" while the Pharmaceutical Services Negotiating Committee (PSNC) looks to recruit Sue Sharpe's replacement, a board member has warned.

Following Ms Sharpe's announcement this week that she will resign at the end of 2017, Mike Hewitson told C+D that pharmacists might not be as fortunate with the next PSNC lead.

"Sue has put in probably the most intense 18-months’ worth of work that any pharmacy representative has put in," he said. "She has been absolutely fighting tooth and nail for community pharmacy 24/7."

While no one was expecting the announcement, he said, "it probably doesn't come as a surprise for a lot of people, because we have all seen how hard she has been working".

Ms Sharpe most recently attended PSNC and the National Pharmacy Association's High Court challenge to the funding cuts in England.

“Now is probably a good time for her to ease off a little bit," Mr Hewitson added.

"This is the most thankless job in pharmacy”, because “whatever you negotiate is not right for somebody”.

"I honestly feel that Sue has played quite a strong hand over a period of time, and pharmacy and extended [parties] will miss her," Mr Hewitson added.

Sue Sharpe: “We need to continue to fight”

In a statement posted on the PSNC website following her announcement, Ms Sharpe said the last 18 months “have been very tough for the sector and for PSNC”.

When making her decision to resign, she had been “confident” the outcome of the judicial review of the funding cuts would have been released. "But we are still waiting," she said. 

"Whatever the outcome of the case, we will need to continue to fight to ensure that pharmacies’ support for patients and role in our communities is protected and developed," she said. "We are preparing the next stages in our campaign."

Numark: Successor must be of "high calibre"

Numark managing director John D’Arcy said the sector is “operating in very difficult, financially strapped times” and PSNC needs a successor of “high calibre” to “fill the very large gap” left by Ms Sharpe.

"We need to secure an engagement and alignment with the Department of Health (DH) and NHS England, which sees pharmacy fully recognised and properly rewarded," he said.

Ms Sharpe has made an “outstanding contribution to pharmacy” by bringing “a considerable skill set” to PSNC, and upholding a “steely determination” in negotiations with the DH, he added.

PSNC chair Mike Pitt said the negotiator "has already begun to consider a recruitment process for a replacement CEO", but finding the "right person...will take time".

What should PSNC look for in its next chief executive?

Related Content

Topics



Pre-reg Trainee
Tonbridge, Kent
 Salary: £22,000
Apply Now
UsernamePublicRestriction

Register

CD008735

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel